CVE-2026-18164: Flow Neuroscience FL-100 · CWE-798
Affects Flow Neuroscience FL-100Source CVE Database V5
Not known to be exploited · CVSS 7.2 High : upgrade to July 2026 soon.
Data as of 12 Nov 2026, 23:24 UTC
- EPSS
- 0.3% chance of exploitation in 30 days – higher than 33% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Patch
- Available – fixed in July 2026
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:N/VA:H/SC:N/SI:N/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 13 Aug 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 13 Nov 2026.
What to do
Upgrade Flow Neuroscience FL-100 to July 2026.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Flow NeuroscienceFL-100 | Affected
| Fixed in
|
| Halo NeuroscienceFL-100 | Affected
| Fixed in
|
AI-suggested
If you cannot patch yet, users should limit Bluetooth exposure and monitor for vendor updates. No official remediation or temporary fixes are currently documented.
Description
CVE-2026-18164 is a vulnerability in the Flow Neuroscience FL-100 device involving an undocumented hard-coded credential shared by all units. This credential allows an attacker within Bluetooth range to bypass authentication and manipulate brain stimulation parameters and device state arbitrarily. The vulnerability has a high severity score of 7.2 and does not currently have an official patch or remediation guidance available.